Optimizing Opioid Dependence Treatment A Guideline for Pharmacists
|
|
- Katrina Ferguson
- 5 years ago
- Views:
Transcription
1 Optimizing Opioid Dependence Treatment A Guideline for Pharmacists Module 1: Substance Use Concepts F e b r u a r y
2 Learning Objectives To know and understand the pathophysiology of substance dependence, the principles of addiction and the harm reduction strategies that are encouraged to increase not only the safety of individuals who use, but also the safety of our communities To recognize the signs and symptoms of opioid intoxication, withdrawal and dependence To know how to use methadone and buprenorphine safely and effectively in the treatment of opioid dependence To be able to apply the NLPB Standards of Practice for the Safe and Effective Provision of Medication for the Treatment of Opioid Dependence to ensure optimal patient care delivery
3 Exemption The NLPB Standards for the Safe and Effective Provision of Medications for the Treatment of Opioid Dependence and the Methadone Maintenance Treatment Standards and Guidelines from the College of Physicians and Surgeons of Newfoundland and Labrador do not apply to the use of methadone or buprenorphine specifically for pain management.
4 Outline Module 1: Substance Use Concepts Module 2: Pharmacotherapy of Opioid Dependence Module 3: Optimal Use of Methadone Module 4: Buprenorphine and Opioid Dependence Module 5: Applying the NLPB Standards of Practice for Opioid Dependence Treatment- Methadone Module 6: Applying the NLPB Standards of Practice for Opioid Dependence Treatment- Buprenorphine Module 7: Case Studies
5 Substance Use Concepts Module One
6 Module 1 - Substance Use Concepts 1. Diagnosis 2. Pathophysiology 3. Harm reduction 4. Principles of addictions treatment 5. Referral resources
7 Substance Use Disorders DSM-5 Diagnostic Criteria Use of the following substances can result in a Substance Use Disorder (SUD): Alcohol Cannabis Hallucinogens Inhalants Opioids Sedatives, anxiolytics Stimulants Tobacco Unknown 11 criteria that encompass impaired control, social impairment, risky use and pharmacological adverse effects Disease severity is based upon the number of criteria present Mild: 2-3 symptoms Moderate: 4-5 symptoms Severe: 6 or more
8 SUD Diagnostic Criteria The individual may take the substance in larger amounts or over a longer period than was originally intended The individual may express a persistent desire to cut down or regulate substance use and may report multiple unsuccessful efforts to decrease or discontinue use The individual may spend a great deal of time obtaining the substance, using the substance, or recovering from its effects Craving is manifested by an intense desire or urge for the drug that may occur at any time but is more likely when in an environment where the drug was previously obtained or used
9 SUD Diagnostic Criteria Recurrent substance use may result in a failure to fulfill major role obligations at work, school or home The individual may continue substance use despite having persistent or recurrent interpersonal problems caused or exacerbated by the effects of the substance Important social, occupational, or recreational activities may be given up or reduced because of substance use There is risky use of the substance where there is recurrent use in situations in which it is physically hazardous
10 SUD Diagnostic Criteria The individual may continue substance use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance Withdrawal is a syndrome that occurs when blood or tissue concentrations of a substance decline in an individual who had maintained prolonged heavy use of the substance Tolerance is signaled by requiring a markedly increased dose of the substance to achieve the desired effect or a markedly reduced effect when the usual dose is consumed
11 The Pathophysiology of Substance Dependence
12 The Dopamine Reward Pathway Drugs are chemicals that tap into the brain s communication system altering the way that neurons normally send, receive and process information Our brains are wired with a dopamine reward circuit that ensures that we will repeat life-sustaining activities by associating these activities with pleasure and reward VTA dopamine rich: Nucleus Accumbens
13 The Dopamine Reward Pathway Some drugs such as heroin and marijuana mimic natural neurotransmitters Other drugs including the psychostimulants cause neurons to release abnormal amounts of natural neurotransmitters or prevent their normal recycling or reuptake Different drugs of abuse alter a variety of neurotransmitter systems Substances of abuse directly or indirectly tap into the dopamine reward pathway
14 The Power of the Dopamine Pathway Activation of the dopamine circuit in the limbic system begins the process through the release of dopamine All drugs of abuse flood this pathway Drugs of abuse can release up to 10 x the amount of dopamine that natural rewards do
15 Contributors to Substance Use Availability Positive and negative reinforcing properties Onset of effect How it is used Orally Mucous membranes Inhaled Injected
16 Classes of Abused Substances CNS depressants Alcohol Opioids: prescribed and illicit such as heroin Benzodiazepines CNS stimulants Cocaine Amphetamines MDMA Ecstasy Crystal meth Methylphenidate Hallucinogens LSD Cannabis THC Psilocybin magic mushrooms Ketamine Solvents Volatile gases and fuels
17 Categories of Substance Use ABST NON- PROB USE AT- RISK USE ABUSE DEP Use Consequences Repetition Loss of control, preoccupation, compulsivity, phys. dep /
18 Harm Reduction Abstinence from use is the ultimate goal It is NOT the only acceptable outcome Harm reduction philosophy Illicit drug use will always happen Minimizing the dangers to individuals, communities and societies is more realistic than condemning it
19 Harm Reduction Principles A set of practical strategies that reduce negative consequences of drug use Safer use Buddy system Injection clinics Condoms Needle exchange
20 SWAP Safe Works Access Program A largely volunteer-driven service established in 2005 which operates under the auspices of ACNL A needle distribution service Aims to reduce the incidence of drug-related health harms including transmission of infection through needle sharing Facilitates referral to primary health care and addictions/ mental health services and Increases public awareness of harm reduction
21 SWAP Statistics Who is using injection drugs in our province? Survey conducted by SWAP Users are both males and females aged 18 + Of various sexual orientations With or without children With differing levels of education including post-secondary degrees and diplomas Those who are working and not working How many needles do they distribute? 60-fold increase since inception of SWAP in approximately 5600 needles In 2012 a staggering 331,833 distributed throughout NL
22 SWAP Benefits Increased awareness and understanding of injection drug use and harm reduction Those injecting drugs engage in safer injection practices and connect to treatment options Decrease in transmission of HIV, Hepatitis B & C Safer communities Should not be viewed as condoning drug use
23 SWAP SWAP offices in St. John s and Corner Brook Tree Walsh, Harm Reduction Outreach Worker Tel: or , Business cards available to provide access to patients Volunteers do not necessarily have the time; they just have the heart. - Elizabeth Andrew
24 Harm Reduction Strategies Managed use Time limited Partial abstinence Controlled use Methadone Maintenance Programs
25 Principles of Addictions Treatment No single treatment is appropriate for all individuals Treatment needs to be readily available Effective treatment attends to multiple needs, not simply drug use Remaining in treatment for an adequate period of time is critical Individual and/or group counseling and other behavioral therapies are critical components of effective treatment Medications are an important element of treatment for many individuals especially when combined with counseling and other behavioral therapies Dependent drug-abusing individuals with coexisting mental illness should have both treated in an integrative way
26 Principles of Addictions Treatment Medical detoxification is only the first stage and by itself does little to change long-term drug use Treatment does not have to be voluntary to be effective Possible drug use during treatment must be assessed through regular on-going monitoring Treatment programs should provide for assessment of HIV, AIDS, Hepatitis B & C, TB and other infectious diseases and provide counseling to help individuals modify or change behaviors that place them or others at risk Recovery from drug addiction can be a long-term process and frequently requires multiple episodes of treatment
27 Addictions Treatment is Multi-Faceted Key to Success: Focus on Individual Needs
28 Resources St. John s Adult Central Intake - Tel: ; Fax: Addiction Services (Outpatient), Community Connections, Community Mental Health Counselling (Mt. Pearl, CBC, Ferryland, Shea Heights, Witless Bay, Bell Island, Portugal Cove- St. Phillips, Torbay, Trepassey) LeMarchant House, Strengths Team (case management), Terrace Clinic, Outpatient Psychiatry Adolescent Central Intake - Tel: ; Fax: Concurrent Disorder Services - Tel: ; Fax: Recovery Center - Tel: ; Fax:
29 Resources St. John s, cont d Opioid Treatment Center - Tel: ; Fax: Outreach and Promotion (youth and adult) - Tel: ; Fax: Rowan Center (Youth Addictions Services) - Tel: ; Fax: Carters Hill Youth Services - Tel: ; Fax: Paradise Wellness - Tel: ; Fax: Methadone Prescriber - Tel: ; Fax:
30 Resources Avalon and Burin Peninsula Mental Health and Addictions Community Counsellors Bay Roberts - Tel: ; Fax: Bonavista - Tel: ; Fax: Marystown - Tel: ; Fax: Clarenville - Tel: ; Fax: Harbour Grace - Tel: ; Fax: Holyrood - Tel: ; Fax: Placentia - Tel: ; Fax: Whitbourne - Tel: ; Fax:
31 Resources Central Mental Health and Addictions Offices Gander - Tel: ; Fax: Badgers Quay - Tel: ; Fax: Grand Falls-Windsor - Tel: ; Fax: Methadone Prescriber - Tel: Methadone Prescriber - Tel: ; Fax:
32 Resources Western Mental Health and Addictions Counsellors Corner Brook - Tel: ; Fax: Burgeo - Tel: ; Fax: Norris Point - Tel: ( x 266); Fax: Springdale - Tel: ; Fax: Port Saunders - Tel: ; Fax: Stephenville - Tel: ; Fax: Deer Lake - Tel: ; Fax: Port Aux Basques - Tel: ; Fax:
33 Resources Western Methadone Prescriber - Tel: ; Fax: Humberwood Treatment Center (referral only) - Tel: ; Fax: Blomidon Place (youth services) - Tel: Labrador Grenfell Health St. Anthony - Tel: ; Fax: Happy Valley-Goose Bay - Tel: ; Fax: Labrador City - Tel: /7413; Fax: Port Hope Simpson - Tel: (x 230) or
34 References Standards for the Safe and Effective Provision for the Treatment of Opioid Dependence. Newfoundland and Labrador Pharmacy Board 2015 Methadone Maintenance Treatment. Standards and Guidelines. College of Physician s and Surgeons of Newfoundland and Labrador 2013 Addiction Treatment Standards. Clinical Guidelines and Standards of Practice in Newfoundland and Labrador. Department of Health and Community Services 2013 Trebault J, Fiellin. Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals. Drugs 2012; 72(2): Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. WHO 2009 Mattick RP, Kimber J, Breen C, Davioli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2008 Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 2008 ACOG Committee Opinion No. 524: Opioid abuse, dependence and addiction in pregnancy. Obstet Gynecol 2012 May; 119(5): Jones H, Finnegan L, Kaltenback K. Methadone and Buprenorphine for the Management of Opioid Dependence in Pregnancy. Drugs April 2012, Vol 72, Issue 6 pp Farrell M, WodakA, Gowing L. Maintenance drugs to treat opioid dependence. BMJ 2012;344:e2823 doi: 10;1136/bmj.e2823 (published May 2012) Orser S, Elkader A. An Update on the Treatment of Opioid Dependence. Pharmacy Practice June 2011 Safe Methadone Practices ISMP Canada
35 Questions? Contact NLPB: Contact Program Developer:
Optimizing Opioid Dependence Treatment A Guideline for Pharmacists
Optimizing Opioid Dependence Treatment A Guideline for Pharmacists Module 3: Optimal Use of Methadone F e b r u a r y 2 0 1 5 Learning Objectives To know and understand the pathophysiology of substance
More informationSubstance Use Disorders
Substance Use Disorders Substance Use Disorder This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
More informationThe Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 1 Expanded to include Gambling Disorder Cannabis Withdrawal and Caffeine Withdrawal are new disorders Caffeine Withdrawal
More informationAddiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine
Addiction Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine Twitter: @rcwallermd Objectives Understand the Concept of Addiction Survival FOOD WATER DOPAMINE
More informationNeurobiology of Drug Abuse and Addiction PSYC 450
Neurobiology of Drug Abuse and Addiction PSYC 450 Healthy Control Drug Abuser Illicit drug use, lifetime and past year, in Canada 50 Canabis only Any drug Any of 5 drugs (without canabis) (CADUMS 2012)
More informationOpiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
More informationNORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationClinical Evaluation: Assessment Goals
Clinical Evaluation: Assessment Goals 1. Define Assessment Process 2. Identify Assessment Instruments 3. Define DSM-5 criteria for Substance Abuse and Dependence, specifiers and multi-axial assessment
More informationNational Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says
National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:
More informationOpioid Use Issues: All the Players
Opioid Use Issues: All the Players Objectives After review, the participant will be able to: 1) Identify criteria for opioid use disorders Andrew J. McLean, MD, MPH Medical Director, ND Department of Human
More informationBASIC VOLUME. Elements of Drug Dependence Treatment
BASIC VOLUME Elements of Drug Dependence Treatment Module 3 Principles of CBT and relapse prevention strategies Introduction to Cognitive Behavioural Therapy Basics of pharmacological treatment Workshop
More informationAppendix F Federation of State Medical Boards
Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction
More informationPrepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over
More informationAll-Party Committee on Mental Health and Addictions. Progress Report
All-Party Committee on Mental Health and Addictions Progress Report October 2015 Background One in five Newfoundlanders and Labradorians live with a mental illness or addiction in any given year. Furthermore,
More informationImportant Information
Important Information Please work through the following pages with your patient or the patient s chart as necessary. Fax completed documents to 1 888 629-4722. Keep the original in your chart / file. Fee:
More informationWasted AN INTRODUCTION TO SUBSTANCE ABUSE
Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING
More informationAcute General Medical and Surgical Admission:
Acute General Medical and Surgical Admission: Managing Substance Use Disorders in Patients Who are Severely Ill Scott Grantham, MD Executive Director, Behavioral Health Saint Francis Health System By the
More informationScientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances
page 1/5 Scientific Facts on Psychoactive Drugs Tobacco, Alcohol, and Illicit Substances Source document: WHO (2004) Summary & Details: GreenFacts Context - Psychoactive drugs such as tobacco, alcohol,
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationUNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph
UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph Summary of Presentation Addiction as a disease Medical harm of substance use Treatment models for substance dependence Local support services for
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationThe Science of Addiction: Genetics and the Brain Webquest
The Science of Addiction: Genetics and the Brain Webquest Part 1: Click here to begin ( might need a laptop not ipad) Complete this chart. Focus on what you DON T REMEMBER FROM HEALTH CLASS. If you know
More informationCouncil on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain
Council on Chemical Abuse Annual Conference November 2, 2017 The Science of Addiction: Rewiring the Brain David Reyher, MSW, CAADC Behavioral Health Program Director Alvernia University Defining Addiction
More informationTHE STATE OF MEDICINE IN ADDICTION RECOVERY
OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,
More informationPolysubstance Use & Medication-Assisted Treatment
Polysubstance Use & Medication-Assisted Treatment DSM-V eliminated polysubstance disorder, instead specifying each drug of abuse and dependence. Substance-use disorder is a combination of the two DSM-IV
More informationNeonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)
Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit
More informationOpioid Analgesics: Responsible Prescribing in the Midst of an Epidemic
Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic Lucas Buffaloe, MD Associate Professor of Clinical Family and Community Medicine University of Missouri Health Care Goals for today
More informationThe available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines
The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs
More information2/21/2018. What are Opioids?
Opioid Crisis: South Carolina Responds Carolyn Bogdon, MSN, FNP-BC Coordinator for Emergency Department Medication Assisted Treatment Program Medical University of South Carolina Opioid Crisis: A Mounting
More informationSUBSTANCE USE DISORDER IN ADOLESCENT POPULATION
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION ANNABELLE SIMPSON, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES
More informationMedication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.
Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation
More informationUnderstanding Addiction: Why Can t Those Affected Just Say No?
Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions
More informationBAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH
BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH THERAPEUTIC INTERVENTION AND RESOURCE MANAGEMENT: SUBSTANCE RELATED DISORDERS: CO-DEPENDENCY AND THE IMPAIRED NURSE LECTURE OBJECTIVES:
More informationMedication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford
Medication Assisted Treatment of an Opioid Use Disorder J. Craig Allen, MD. Medical Director, Rushford Learning objectives At the conclusion of this activity, participants will be able to: Understand
More informationDSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW
DSM-5 AND ASAM CRITERIA Presented by Jaime Goffin, LCSW MODULE 1: GOALS & OBJECTIVES What is your experience with using ASAM and DSM 5 criteria? What are your learning expectations for today? GOAL FOR
More informationTHE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.
THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.
More informationUnderstanding Drug and Alcohol Abuse and Addiction
Understanding Drug and Alcohol Abuse and Addiction Peter R. Martin, M.D. Professor of Psychiatry and Pharmacology Vanderbilt Addiction Center Substance Use, Abuse, and Addiction Inexorably intertwined
More informationAnnual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use
Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Report of the Government of: Reporting Year: Completed on (date): Please return completed questionnaire to: arq@unodc.org
More informationHIV and alcohol use: why is risk reduction in alcohol use important in HIV care?
HIV and alcohol use: why is risk reduction in alcohol use important in HIV care? Susanne Astrab Fogger, DNP, PMHNP-BC, CARN-AP, FAANP sfogger@uab.edu Objectives for today s session Define alcohol use disorder
More informationTable of Contents Interim Report of the OxyContin Task Force, Newfoundland & Labrador, January 30, 2004
OXYCONTIN TASK FORCE INTERIM REPORT January 30, 2004 Submitted to Hon. Elizabeth Marshall, Minister of Health & Community Services, Government of Newfoundland and Labrador Table of Contents INTRODUCTION
More informationInterdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings
Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings BRIAN GARVEY, MD, MPH REBECCA CANTONE, MD OREGON HEALTH & SCIENCE UNIVERSITY SCAPPOOSE RURAL HEALTH CENTER Disclosures
More informationTHE ADDICTIVE BRAIN SC 212 JANUARY 3, 2017 JOHN BUSH
THE ADDICTIVE BRAIN SC 212 JANUARY 3, 2017 JOHN BUSH ADDICTS ADDICTIONS? WHAT CAUSES ADDICTIONS? Addiction is the result of substance abuse by people with moral failings or personality defects. Addiction
More informationRestoration of Parenting Ability Through Treatment for Substance Use Disorders
Restoration of Parenting Ability Through Treatment for Substance Use Disorders DEBRA M. BARNETT, MD Board Certified in General Psychiatry, Addiction Psychiatry, Geriatric Psychiatry, and Forensic Psychiatry
More informationBRAIN MECHANISMS OF REWARD AND ADDICTION
BRAIN MECHANISMS OF REWARD AND ADDICTION TREVOR.W. ROBBINS Department of Experimental Psychology, University of Cambridge Many drugs of abuse, including stimulants such as amphetamine and cocaine, opiates
More informationFaculty of Medicine THE DISCIPLINE OF FAMILY MEDICINE RESIDENCY TRAINING PROGRAM
Faculty of Medicine THE DISCIPLINE OF FAMILY MEDICINE RESIDENCY TRAINING PROGRAM TABLE OF CONTENTS Map of Teaching Sites... 1 Family Medicine Residency Information... 2 STREAMS Eastern (EastFam)... 4
More informationALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH
ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV
More informationMedications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?
Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives
More informationMASS COMMUNICATIONS The traditional realm of mass communications includes television,
Appendix C: Perspectives on Defining Substance c Abuse F our broad arenas that encounter substance abuse-related issues include, mass communications, criminal justice, medicine, and public health. These
More informationNIDA Quick Screen V1.0F1
NIDA Quick Screen V1.0F1 Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to ask you a few
More informationsubstance use and mental disorders: one, the other, or both?
substance use and mental disorders: one, the other, or both? Stephen Strobbe, PhD, RN, PMHCNS-BC, CARN-AP Dawn Farm Education Series St. Joe s Education Center, Ypsilanti, MI Tuesday, January 27, 2015
More informationAt a Glance. Background Information. Lesson 3 Drugs Change the Way Neurons Communicate
Lesson 3 Drugs Change the Way Neurons Communicate Overview Students build upon their understanding of neurotransmission by learning how different drugs of abuse disrupt communication between neurons. Students
More informationDr. Solomon Derese. Department of Chemistry University of Nairobi
Dr. Solomon Derese Department of Chemistry University of Nairobi sderese@uonbi.ac.ke 1 Alcohol and Drug Addiction 3 The word addiction is derived from a Latin term for enslaved by or bound to 4 Addiction
More informationMethadone 6. meth : physeptone : juice WHAT & WHY? No. 6 in a series of guides to help people understand what drugs are and why people take them
WHAT & WHY? Methadone 6 meth : physeptone : juice No. 6 in a series of guides to help people understand what drugs are and why people take them SECOND EDITION What? Methadone is one of a large number
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) What has changed? Effective January 16, 2018, Coordinated Care will change the requirement for form HCA 13-333 Medication
More informationNeuroscience of Addiction
Neuroscience of Addiction Carlton Erickson, Ph.D. Associate Dean for Research and Graduate Studies Distinguished Professor of Pharmacology Director, Addiction Science Research and Education Center College
More informationRevised 9/30/2016. Primary Care Provider Pain Management Toolkit
Revised 9/30/2016 Primary Care Provider Pain Management Toolkit TABLE OF CONTENTS 1. INTRODUCTION Page 1 2. NON-OPIOID SERVICES &TREATMENTS FOR CHRONIC PAIN Page 2 2.1 Medical Services Page 2 2.2 Behavioral
More informationSubstance Abuse Level of Care Criteria
Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:
More informationHow Addiction Affects the Brain: The Neuroscience of Compulsive Behavior
How Addiction Affects the Brain: The Neuroscience of Compulsive Behavior Table of Contents INTRODUCTION.... 3 NEUROSCIENCE 101: NEURONS AND NEUROTRANSMITTERS.... 4 BRAIN REGIONS INVOLVED IN ADDICTION:
More informationAn Internist s Guide to Unhealthy Alcohol Use. Ryan Graddy, MD JHU SOM
An Internist s Guide to Unhealthy Alcohol Use Ryan Graddy, MD JHU SOM Disclosures None Learning Objectives Understand the terminology used to describe unhealthy alcohol use Identify means of screening
More informationEvidence based Practices
Evidence base Practices Adjunct Professor of Psychology, Western Carolina University President, Evince Clinical Assessments Evidence based Treatment Utilize treatment models documented to be effective
More informationThe Science of Addiction Webquest
1 The Science of Addiction Webquest For this assignment you will be using the website of The University of Utah s Genetic Science Learning Library (http://learn.genetics.utah.edu/content/addiction/). For
More informationEVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO
EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More information9. In comparing the relative toxicity of marijuana and cocaine, it is important to take into account A. the user's gender. B. availability and price.
02 Student: 1. The Canadian government, in the early 1900s had virtually no laws regulating the sale and use of drugs. In general the government took a "hands-off" approach that has been referred to as
More informationModels of good practice in drug treatment in Europe. Project group
Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
More informationReferral to the Women s Alcohol and Drug Service (WADS) Procedure
Procedure Referral to the Women s Alcohol and Drug Service (WADS) Procedure. Purpose The following document describes criteria for the referral to Women s Alcohol and Drug Service (WADS) and how a referral
More informationReaching Out: Creating Synergy among Urban and Rural Mental Health Providers while Enhancing Group Work Capacity with Children and Families
Reaching Out: Creating Synergy among Urban and Rural Mental Health Providers while Enhancing Group Work Capacity with Children and Families Janice C. Burke, M.A., R. Psych. Natasha Curran, M.Sc., R. Psych.
More informationPatient Care Planning Group April 3, 2014
Patient Care Planning Group April 3, 2014 Philip O. Toal, Ed.D,; LMHC, CET Administrator, Non-Residential Services The Center For Drug Free Living, a founding partner of Aspire Health Partners Participants
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) For Apple Health clients served Fee-for-Service and through contracted Medicaid Managed Care Organizations Updated January
More informationPresentation to PPI Thursday 17 th May 2012 GILL HESSION - Manager. Appendix 1
Presentation to PPI Thursday 17 th May 2012 GILL HESSION - Manager Appendix 1 TOP 20 DRUGS A team of leading scientists spent two years analysing the effects of 20 of Britain s most widely used drugs,
More informationOverview. APPLIED PREVENTION & intervention STRATEGIES. APPLIED PREVENTION & intervention STRATEGIES
Overview in the Context of a Comprehensive System of Care Overview of Evidence-Based Brief Motivational Interventions Screening and Referral Overview Session 1 Session 2 2 APPLIED PREVENTION & intervention
More informationA Comprehensive Model of Stepped Care for Substance Misuse Prevention on a College Campus
A Comprehensive Model of Stepped Care for Substance Misuse Prevention on a College Campus Steven W. Clarke, PhD Director of Health Promotion & Prevention Services Binghamton University Jennifer F. Wagstaff,
More informationAn overview of Medication Assisted Treatment (MAT) and acute pain management on MAT
An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT Goals of Discussion Recognize opioid use disorder (OUD) Discuss the pharmacology of medication assisted treatments (MAT)
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners Grand Rounds October 11, 2017 Disclosures One
More informationCalvert County Public Schools Health Education Curriculum High School
Calvert County Public Schools Health Education Curriculum High School Introduction The high school health education curriculum was created using the Health Education Curriculum Analysis Tool (HECAT) provided
More informationCritiquing the Construction of Addiction: Dependence, Disorder and the DSM V
Critiquing the Construction of Addiction: Dependence, Disorder and the DSM V Helen Keane School of Sociology Australian National University Addiction A hybrid moral medical category defined by pathological
More informationAmphetamine 2. speed : whizz : base : amphet : sulphate WHAT & WHY?
WHAT & WHY? Amphetamine 2 speed : whizz : base : amphet : sulphate No. 2 in a series of guides to help people understand what drugs are and why people take them SECOND EDITION What? Illicit amphetamine
More informationThe Importance of Psychological Treatment and Behavioral Support
The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding
More informationSubstance Use and Mental Health Disorders: Challenges for Primary Care
Substance Use and Mental Health Disorders: Challenges for Primary Care Ted Parran MD FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@cwru.edu Euphoria Producing Drugs
More informationIII. FREQUENTLY ASKED QUESTIONS
III. FREQUENTLY ASKED QUESTIONS 1. Why do adolescents take drugs? Adolescents experiment with drugs or continue taking them for several reasons, including: To fit in: Many teens use drugs because others
More informationMany drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age.
1 Chapter 12 Section 1 Objectives List six ways illegal drug use can be dangerous. State five reasons a person might try illegal drugs. Identify the reason drug abuse is especially dangerous to teens.
More informationThe Biology of Addiction
The Biology of Addiction Risk factors for addiction: Biological/Genetic Family history of addiction Being male Having mental illness Exposure to substances in utero * The genes that people are born with
More informationModule Three Screening and Assessment V
Module Three Screening and Assessment V1.7.13.141031 Introduction to Modules Three and Four Modules Three and Four cover the key components of SBIRT screening, assessment and brief intervention. The screening,
More informationMark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC
Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01
More informationSpecial Topic: Drugs and the Mind
BIOLOGY OF HUMANS Concepts, Applications, and Issues Fifth Edition Judith Goodenough Betty McGuire 8a Special Topic: Drugs and the Mind Lecture Presentation Anne Gasc Hawaii Pacific University and University
More informationREFERRAL SOURCE GUIDELINES. Listed below is a general outline of the referral, interview and intake process at Last Door Recovery Centre.
REFERRAL SOURCE GUIDELINES Listed below is a general outline of the referral, interview and intake process at Last Door Recovery Centre. 1. Contact Last Door Recovery Centre at 1 888 525 9771 to determine
More informationHot Topics in Addiction Medicine. Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017
Hot Topics in Addiction Medicine Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017 Financial Disclosures Speaker Bureau Indivior Research Support Constellation Health Onward Hot Topics
More informationCSAM-SCAM Fundamentals. Cocaine Basics. Presentation provided by David C. Marsh MD CCSAM
CSAM-SCAM Fundamentals Cocaine Basics Presentation provided by David C. Marsh MD CCSAM Chronic Illness Relapsing & Remitting in Course Genetic Predisposition Individual Choice a Factor Environmental Influence
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationSubstance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %
Substance Use Disorders A Major Problem Lifetime rates of alcoholism estimated at 13.4 % Rates of drug abuse estimated at 6% Marijuana is most frequent Approximately 600,000 deaths each year from substance
More informationWHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS
WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS René Lento, PhD Lauren Brenner, PhD September 25, 2018 DISCLOSURES None HOME BASE PROGRAM 3 LEARNING OBJECTIVES
More informationControlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing
Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing Mississippi Primary Health Care Association Pearl, MS March 7, 2018 Scott Hambleton, MD, DFASAM Medical
More informationStimulant users are sensitive to the stimulant properties of alcohol as indexed by alcohol-induced heart rate increase
Washington University School of Medicine Digital Commons@Becker Posters 2004: Alcoholism and the Latest Genetics and Neuroscience Findings 2004 Stimulant users are sensitive to the stimulant properties
More informationIllegal drugs. Epidemiology &Prevention
Illegal drugs Epidemiology &Prevention Classification Legal drug abuse Substance abuse Prescription drugs Sedatives/hypnotics Alcohol Tobacco Volatile solvents Non-substance abuse Gambling addiction Internet
More informationBuprenorphine & Controlled Substance Treatment Agreement
Buprenorphine & Controlled Substance Treatment Agreement I agree to accept the following treatment contract for buprenorphine office-based opioid addiction treatment: 1. I will keep my medication in a
More informationMedical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine
Medical Interventions for Addiction in Primary Care Settings R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine March 23, 2010 NIH Consensus on Drug Treatment Drug Addiction
More informationSubstance use and misuse
An open learning programme for pharmacists and pharmacy technicians Substance use and misuse Educational solutions for the NHS pharmacy workforce DLP 160 Contents iii About CPPE open learning programmes
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification
More informationDrug related hospital stays in Australia
Prepared by Funded by Amanda Roxburgh and Courtney Breen, National Drug and Alcohol Research Centre the Australian Government Department of Health Recommended Roxburgh, A. and Breen, C (217). Drug-related
More information